Hema Parmar

Estrogen Receptor β Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest

Sreenivasan Paruthiyil, Hema Parmar, Vaishali Kerekatte et al. · Cancer Research · 2004 · 570 citations

Breast Oncology, Medicine, Mcf-7 Cells +11

Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma.

Robert J. Motzer, Ashok Rakhit, Lawrence H. Schwartz et al. · PubMed · 1998 · 231 citations

Immunology, Immunoediting, Pharmacotherapy +16

Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors

Dejan Juric, Ian E. Krop, Ramesh K. Ramanathan et al. · Cancer Discovery · 2017 · 159 citations · Full text

Cytoskeletal microdifferentiation: A mechanism for organizing morphological plasticity in dendrites

Stefanie Kaech, Hema Parmar, Martijn Roelandse et al. · Proceedings of the National Academy of Sciences · 2001 · 123 citations · Full text

Biophysical Modeling, Engineering, Morphological Plasticity +22

Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial

Chung‐Han Lee, Robert J. Motzer, Hamid Emamekhoo et al. · Clinical Cancer Research · 2022 · 97 citations · Full text